Sandoz Inc v. Eli Lilly Co

Mark D. Schuman

Sandoz targets Eli Lilly’s antifolate therapy patent: obviousness cited for all 22 claims over combining vitamin B12 with folic acid pretreatment.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Jacqueline W Bonilla	400+	53%	71%
Lora M Green	400+	54%	71%
Michael P Tierney	300+	71%	78%
Michael P Tierney	300+	71%	78%
Tina E Hulse	400+	59%	68%

Name	Ratings
Sandoz Inc	L2 E
Mylan Laboratories Ltd	L5 A
Apotex Corp	L5 A
Apotex Inc	L5 A
Teva Pharmaceuticals USA Inc	L3 A
Fresenius-Kabi USA LLC	L3 B
Glenmark Pharmaceuticals Inc	L2 B
Glenmark Pharmaceuticals Ltd	L2 B
Glenmark Holding SA	L2 B
Wockhardt Bio AG	L2 B
Heritage Pharma Labs Inc	L1 C
Emcure Pharmaceuticals Ltd	L1 C
Heritage Pharmaceuticals Inc	L1 C

Name	Ratings
Alston & Bird LLP	L5 B
Thomas J. Parker	L2 C
Crowell & Moring LLP	L5 E
Ralph J. Gabric	L3 D
Joshua James	L2 B
Goodwin Procter LLP	L5 E
Cynthia L. Hardman	-- -- --
Carlson Caspers Vandenburgh Lindquist Schuman PA	L2 E
Mark D. Schuman	L3 D
Gary J. Speier	L1 C

Name	Ratings
Eli Lilly & Co	L3 C
Eli Lilly Co	L3 C